Guide for the prevention and treatment of glucocorticoid-induced osteoporosis of the Spanish Society of Internal Medicine;Guía de prevención y tratamiento de la osteoporosis inducida por glucocorticoides de la Sociedad Española de Medicina Interna

Revista Clinica Espanola

Volumn 208, Issue 1, 2008, Pages 33-45

  Sosa Henriquez M ^a,b   Diaz Curiel M ^a   Diez Perez A ^a   Gomez Alonso C ^a   Gonzalez Macias J ^a   Farrerons Minguella, J ^a   Filgueira Rubio, J ^a   Mellibovsky Saidler, L ^a   Nogues Solan X ^a   Hernandez Hernandez D ^a  

^a Grupo de Trabajo en Osteoporosis de la Sociedad Española de Medicina Interna

^b UNIVERSITY OF LAS PALMAS DE GRAN CANARIA   (Spain)

Author keywords

Alendronate; Bisphosphonates; Densitometry; Fracture; Osteoporosis; Parathiroid hormone; Prevention; Risedronate; Steroides; Treatment

Indexed keywords

ALENDRONIC ACID; ALFACALCIDOL; BISPHOSPHONIC ACID DERIVATIVE; CALCITONIN; CALCIUM; CLODRONIC ACID; ETIDRONIC ACID; FLUORIDE SODIUM; GLUCOCORTICOID; IBANDRONIC ACID; PARATHYROID HORMONE; PARATHYROID HORMONE[1-34]; PREDNISONE; RISEDRONIC ACID; VITAMIN D;

ARTICLE; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; FRAGILITY FRACTURE; HUMAN; MALE; MEDICAL SOCIETY; OSTEOPOROSIS; PATHOPHYSIOLOGY; POSTMENOPAUSE OSTEOPOROSIS; PREMENOPAUSE; REPRODUCIBILITY; SPAIN; VITAMIN SUPPLEMENTATION;

EID: 39749164636     PISSN: 00142565     EISSN: 15781860     Source Type: Journal    
DOI: 10.1157/13115006     Document Type: Article

References (120)